A Randomized Control Trial on effect of Halotherapy in improving airway clearance among patient with COPD admitted in selected tertiary care hospital of Western Maharashtra.

Hypertonic saline nebulization therapy Procedure:  Random sampling of patients will be done. On admission mortality assessment will be done by DECAF score. Sample will be equally divided into 2 groups (Intermediate & High risk).  Random sampling will be done to devide them in experimental and control grop.Experimental group will be administered 3% hypertonic saline nebulisation after routine broncodilator neblisation for 10 mins 6 hrly in a day for 07 days and control group will receive routine broncodilator neblisation treatment of exacerbation of COPD. Both groups will have control and experimental group. Groups will be assessed by modified borg scale, peak flow, duration of hospital stay, need of invasive ventilation & 30 day mortality with Spirometry, pulse oximetry, heart rate recording & respiratory rate recording to ensure the evidence of bronchospasm. Both the pre intervention and post intervention scores will be entered in coding sheet.